Loading organizations...
Loading organizations...
PiSA Farmacéutica specializes in the development and manufacturing of a broad portfolio of pharmaceutical products and healthcare services for both public and private sectors. The company produces a wide array of medications, including pediatric formulations, oral rehydration solutions, large volume parenteral solutions, antibiotics, oncology treatments, and hormonal products, alongside advanced medical devices such as electro-medical equipment for automated peritoneal dialysis. Its integrated approach serves healthcare needs across Mexico, the United States, Latin America, and the Caribbean.
The company was established in 1945 by Professor Miguel Álvarez Ochoa, who recognized a critical unmet need for pediatric-specific pharmaceutical products when existing treatments were inadequate for children. He started by manufacturing ten children’s products, a novel approach at the time, with the support of several doctors including Luis Farah Mata and Francisco Ruiz Sánchez. This foundational insight into specialized patient care propelled the company’s initial growth and expansion.
PiSA Farmacéutica’s comprehensive product offerings serve diverse segments within the public and private healthcare systems. The company is committed to its mission of operating as a reputable and morally-minded business dedicated to excellent customer service, employee welfare, and health promotion. Its long-term vision is to achieve lasting impact through continuous innovation, fostering accelerated growth and expanding its reach both within Mexico and internationally.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 12, 2020 | X-COR Therapeutics | $2.6M COR Therapeutics - Seed | Gabriele Brambilla | Flybridge Capital Partners, Good Growth Capital |